Results 11 to 20 of about 2,596 (118)

Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols. [PDF]

Hemasphere, 2023
HemaSphere, Volume 7, Issue 1, January 2023.
Barba P, Morgades M, Montesinos P, Gonzalez-Campos J, Torrent A, Gil C, Bernal T, Tormo M, Mercadal S, Novoa S, García-Cadenas I, de Llano MPQ, Cervera M, Coll R, Bermudez A, Amigo ML, Monsalvo S, Esteve J, Garcia-Boyero R, Novo A, Hernandez Rivas JM, Cladera A, Martinez-Sanchez P, Serrano J, Artola MT, Soria B, Abella E, Vall-Llovera F, Bergua J, Herrera P, Barrios D, Ribera JM.   +31 more
europepmc   +2 more sources

P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS [PDF]

Hemasphere, 2022
HemaSphere, Volume 6, Issue S3, Page 1583-1584, June 2022.
Barba P, Morgades M, Montesinos P, Gonzalez Campos J, Torrent A, Gil C, Bernal T, Tormo M, Mercadal S, Saumell S, García-Cadenas I, Queipo de Llano M, Cervera M, Coll R, Bermudez A, Amigo M, Monsalvo S, Esteve J, Garcia Boyero R, Novo A, Hernandez Rivas J, Cladera A, Martinez-Sanchez P, Serrano J, Artola M, Soria B, Abella E, Vall-Llobera F, Bergua J, Herrera P, Barrios D, Ribera J.   +31 more
europepmc   +2 more sources

Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols

British Journal of Haematology, Volume 196, Issue 3, Page 670-675, February 2022., 2022
Summary The prognosis of t(1;19)(q23;p13)/transcription factor 3‐pre‐B‐cell leukaemia homeobox 1 (TCF3‐PBX1) in adolescent and adult patients with acute lymphoblastic leukaemia (ALL) treated with measurable residual disease (MRD)‐oriented trials remains controversial. In the present study, we analysed the outcome of adolescent and adult patients with t(
Jordi Ribera, Isabel Granada, Mireia Morgades, Teresa González, Juana Ciudad, Esperanza Such, María‐José Calasanz, Santiago Mercadal, Rosa Coll, José González‐Campos, Mar Tormo, Irene García‐Cadenas, Cristina Gil, Marta Cervera, Pere Barba, Dolors Costa, Rosa Ayala, Arancha Bermúdez, Alberto Orfao, Josep‐Maria Ribera, on behalf of the Programa para el Tratamiento de Hemopatias Malignas (PETHEMA) Group (Spanish Society of Hematology, SEHH)   +21 more
wiley   +1 more source

Index of Authors and Co‐Authors [PDF]

United European Gastroenterol J, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 908-938, October 2021.
europepmc   +2 more sources

Index of Authors and Co‐Authors [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue S8, Page 1559-1604, October 2025.
europepmc   +2 more sources

UEG Week 2021 Moderated Posters [PDF]

United European Gastroenterol J, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 163-259, October 2021.
europepmc   +2 more sources

EHA2021 Virtual Congress Abstract Book

, 2021
HemaSphere, Volume 5, Issue S2, June 2021.
wiley   +1 more source

Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020

, 2020
HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
wiley   +1 more source

EHA2024 Hybrid Congress [PDF]

Hemasphere
HemaSphere, Volume 8, Issue S1, June 2024.
europepmc   +2 more sources

23rd Congress of the European Hematology Association Stockholm, Sweden, June 14‐17, 2018

, 2018
HemaSphere, Volume 2, Issue S1, Page 1-1113, June 2018.
wiley   +1 more source